MedPath

Education with short message service and adherence

Not Applicable
Conditions
Rheumatic heart valve diseases.
Chronic rheumatic heart diseases
I05, I06,
Registration Number
IRCT2012102011177N1
Lead Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients who have prosthetic heart valves and their surgery are at least two months ago.
Patients who take warfarin at least three months after surgery and their International Normalized Ratio (INR) must continuously be controlled.
Patients who have at least literate to read and write.
Patients who have a mobile phone at their home.
Patients who have not vision problems or have access to a third party who is able to read and write a short message for them.
Patients who have not speech, hearing and psychological problems.
The age range is between 18-65 years.
Exclusion criteria:
Changes in the medication.
Hospitalization for any reason.
Patient's reluctance to continue working.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence to treatment. Timepoint: Before the intervention, three months after the intervention. Method of measurement: Self-report questionnaire, INR.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath